Journal of the National Cancer Center

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of the National Cancer Center is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,700 USD. Declared review time at DOAJ: 49 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2667-0054
Country
Netherlands
Languages
english
Access
Open access
Declared publication charge
2,700 USD
Articles in DOAJ
254
Declared review time
49 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-11-11
Indexing
DOAJ
APC
2,700 USD
Declared review time (DOAJ)
49 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

254

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

49weeks

Works in OpenAlex

291

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

24

i10-index

70

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2026-04-27
Added to DOAJ
2021-11-11
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
92%
ORCID iDs in current deposits
73%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
JNCCBeijing shuxue zazhi (Yingwen
Source type
journal
NLM unique ID (PubMed)
9918334970706676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
Show all subjects (50)
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Cancer Cells and Metastasis
  • Lung Cancer Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Lung Cancer Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Esophageal Cancer Research and Treatment
  • Cancer Cells and Metastasis
  • Radiomics and Machine Learning in Medical Imaging
  • Multiple and Secondary Primary Cancers
  • Multiple and Secondary Primary Cancers
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Ferroptosis and cancer prognosis
  • Prostate Cancer Treatment and Research
  • Ferroptosis and cancer prognosis
  • Prostate Cancer Treatment and Research
  • Gastric Cancer Management and Outcomes
  • Genetic factors in colorectal cancer
  • Head and Neck Cancer Studies
  • Genetic factors in colorectal cancer
  • Head and Neck Cancer Studies
  • Breast Cancer Treatment Studies
  • Immunotherapy and Immune Responses
  • Breast Cancer Treatment Studies
  • Gastric Cancer Management and Outcomes
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • CAR-T cell therapy research
  • Circadian rhythm and melatonin

Keywords (DOAJ)

  • cancer
  • oncology
  • haematology
  • tumor
  • tumor immunotherapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: